UCLA doctors successfully 'vacuum' two-foot blood clot out of patient's heart

September 18, 2013

Todd Dunlap, 62, arrived at Ronald Reagan UCLA Medical Center's emergency room on Aug. 8 suffering from shortness of breath, fatigue and extreme cold. When a CT scan revealed a 24-inch clot stretching from his legs into his heart, doctors feared the mass could break loose and lodge in his lungs, blocking oxygen and killing him instantly.

Dr. John Moriarty gave his patient a choice. Dunlap could have open-heart surgery or undergo a new minimally using a device called AngioVac to vacuum the massive clot out of his heart. The catch? The procedure had never been successfully performed in California.

A new grandfather, Dunlap didn't hesitate to choose the second option and underwent the procedure on Aug. 14. A week later, he was home, full of energy and eager to play on the floor with his 9-month-old grandson.

Here's how it worked: A team of UCLA interventional radiologists and cardiovascular surgeons slid a down Dunlap's esophagus to visually monitor his heart. Next, they guided a coiled hose through his and plugged one end into his heart, against the clot. They threaded the other end through a vein at the groin and hooked the hose up to a powerful heart-bypass device in the operating room to create suction.

"Once in place, the AngioVac quickly sucked the deadly clot out of Mr. Dunlap's heart and filtered out the solid tissue," said Moriarty, a UCLA interventional radiologist with expertise in clot removal and . "The system then restored the cleansed blood through a blood vessel near the groin, eliminating the need for a ."

The procedure lasted three hours. Doctors observed Dunlap for three days in intensive care before transferring him to the hospital's cardiac ward and then discharging him four days later.

Open-heart surgery takes twice as long to perform and often requires the surgeon to divide the breastbone lengthwise down the middle and spread the halves apart to access the heart. After the heart is repaired, surgeons use wires to hold the and ribs in place as they heal. The procedure can necessitate extended rehabilitation before the patient makes a full recovery.

"Retrieving a clot from within the heart used to require open-heart surgery, resulting in longer hospitalization, recovery and rehabilitation times compared to the minimally invasive approach provided by the AngioVac system," said Dr. Murray Kwon, a UCLA cardiothoracic surgeon who collaborated on Dunlap's procedure.

Similarly, a clot-busting drug known as a tPA typically takes three to four days to work. In Dunlap's case, his physicians tried tPA first, but it failed due to the clot's large size and density.

"The AngioVac was the last resort for Mr. Dunlap," said Moriarty. "The clot clogged his heart chamber like a wad of gum in a pipe. Every moment that passed increased the risk that the clot would migrate to his lungs and kill him. We couldn't have asked for a better outcome."

"I'm thrilled that I didn't have to go through open-heart surgery," said Dunlap, a resident of Newbury Park, Calif., who is the father of two adult sons. "This procedure is a great option for the older, frail person who wouldn't survive open-heart surgery. Without an alternative like this, he's a goner."

Like Dunlap, roughly one in 500 Americans suffers from blood clots in the leg veins, a condition called deep vein thrombosis. Estimates double in people older than 80. Nearly 100,000 Americans die each year when a clot breaks away from the blood-vessel wall and lodges in the lungs or . In one of every four cases, sudden death is the only clue an individual is suffering from the condition.

"When you hear about new cutting-edge options, it gives you hope," said Cheryl Dunlap, who has been married to Todd for 32 years. "Without it, you run into a brick wall. If we'd consulted only with our community hospital and not a teaching facility like UCLA, we wouldn't have learned about all the treatment choices available to us."

"It takes a large team of experts to perform a potentially high-risk procedure like this for the first time," Moriarty said. "We couldn't have been successful without the collaboration of our colleagues in cardiac surgery, radiology, cardiology and anesthesia."

Explore further: Henry Ford Hospital pioneers new cardiac approach

Related Stories

Henry Ford Hospital pioneers new cardiac approach

August 13, 2013
Doctors at Henry Ford Hospital have created a new route to the heart to implant an artificial heart valve by temporarily connecting major blood vessels that do not normally intersect.

New coating may reduce blood clot risk inside stents

September 5, 2013
Coating artery-opening stents with a new compound may someday eliminate a common side effect of the treatment, according to preliminary research in the American Heart Association journal Arteriosclerosis, Thrombosis, and ...

UCLA uses new device to replace aortic valve in patients who can't have open-heart surgery

August 16, 2012
(Medical Xpress) -- UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who ...

Cleveland Clinic study finds lowest risk treatment for severe carotid and coronary disease

July 31, 2013
Of the three most common treatment approaches for patients with severe carotid and coronary artery disease, patients who underwent stenting of the carotid artery followed by open heart surgery had the best outcomes, according ...

Heart doctors repair coronary aneurysm without open surgery

February 16, 2012
(Medical Xpress) -- Methodist DeBakey Heart & Vascular Center interventional cardiologists have, for the first time, repaired a large coronary artery aneurysm with stent-assisted coil embolization without doing open heart ...

Fully dissolvable, temporary stent for opening heart artery blockages

September 17, 2013
The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.